Correlates and Consequences of Increased Immune Activation in Injection Drug Users
Status
Conditions
Treatments
Details and patient eligibility
About
The goal of this study is to learn how injection drug use may affect the immune system.
Full description
The goal of this study is to learn how injection drug use may affect the immune system. One way to measure this is by looking at the blood and the gut, or gastrointestinal tract at the same time. It is thought that activating the immune system by injection drug use may increase destruction of immune cells in the gut. To test this theory, the investigators are enrolling HIV-negative injection drug users, HIV-negative people who do not use drugs and HIV-negative former injection drug users.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Ability to give informed consent
- Between the ages of 18 and 55
- Absence of medical conditions that would preclude flexible sigmoidoscopy
- Absence of active opportunistic infection requiring active therapy including antibiotics or anti-neoplastics (note this does not include prophylactic antibiotic therapy)
Exclusion criteria
- History of bleeding disorder
- Platelet count below 70,000
- INR>1.5 or PTT>2X control
- Active use of anticoagulants or aspirin therapy that cannot be interrupted
- Comorbid diagnosis of inflammatory bowel disease
- Pregnancy, incarceration, mentally disabled individuals
- HIV-1 infection
- Currently on Hepatitis C treatment
Trial design
201 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal